Quadrature Capital Ltd Makes New $5.44 Million Investment in The Cooper Companies, Inc. (NASDAQ:COO)

Quadrature Capital Ltd bought a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 53,610 shares of the medical device company’s stock, valued at approximately $5,437,000.

Several other large investors have also recently made changes to their positions in the business. SG Americas Securities LLC raised its holdings in shares of Cooper Companies by 220.9% in the 4th quarter. SG Americas Securities LLC now owns 4,326 shares of the medical device company’s stock worth $1,637,000 after purchasing an additional 2,978 shares during the period. Raymond James & Associates lifted its position in shares of Cooper Companies by 2.3% during the 4th quarter. Raymond James & Associates now owns 143,961 shares of the medical device company’s stock valued at $54,481,000 after buying an additional 3,298 shares during the last quarter. Assenagon Asset Management S.A. lifted its position in shares of Cooper Companies by 207.4% during the 4th quarter. Assenagon Asset Management S.A. now owns 42,493 shares of the medical device company’s stock valued at $16,081,000 after buying an additional 28,669 shares during the last quarter. Altfest L J & Co. Inc. grew its stake in shares of Cooper Companies by 22.5% during the 4th quarter. Altfest L J & Co. Inc. now owns 1,257 shares of the medical device company’s stock worth $476,000 after acquiring an additional 231 shares during the period. Finally, MJP Associates Inc. ADV increased its holdings in Cooper Companies by 6.1% in the 4th quarter. MJP Associates Inc. ADV now owns 906 shares of the medical device company’s stock worth $343,000 after acquiring an additional 52 shares during the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Price Performance

Shares of COO stock traded up $0.53 during trading hours on Friday, hitting $93.21. 1,063,395 shares of the company’s stock were exchanged, compared to its average volume of 1,241,350. The company has a market capitalization of $18.56 billion, a PE ratio of 54.75, a PEG ratio of 2.30 and a beta of 0.98. The company has a current ratio of 1.95, a quick ratio of 1.14 and a debt-to-equity ratio of 0.34. The Cooper Companies, Inc. has a 12-month low of $75.93 and a 12-month high of $104.07. The business’s 50 day simple moving average is $91.31 and its 200-day simple moving average is $94.29.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, May 30th. The medical device company reported $0.85 EPS for the quarter, topping the consensus estimate of $0.83 by $0.02. Cooper Companies had a return on equity of 8.87% and a net margin of 9.11%. The firm had revenue of $942.60 million for the quarter, compared to the consensus estimate of $948.07 million. During the same quarter in the previous year, the business earned $0.77 earnings per share. The company’s quarterly revenue was up 7.4% on a year-over-year basis. On average, equities research analysts anticipate that The Cooper Companies, Inc. will post 3.57 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research firms recently commented on COO. Piper Sandler reaffirmed an “overweight” rating and issued a $115.00 price objective on shares of Cooper Companies in a report on Wednesday, July 3rd. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a report on Friday, May 31st. Citigroup boosted their price objective on Cooper Companies from $108.00 to $116.00 and gave the company a “buy” rating in a research note on Wednesday, April 3rd. Jefferies Financial Group raised Cooper Companies from a “hold” rating to a “buy” rating and increased their price objective for the stock from $107.00 to $115.00 in a report on Tuesday, July 16th. Finally, Robert W. Baird lifted their target price on Cooper Companies from $116.00 to $118.00 and gave the company an “outperform” rating in a report on Friday, May 31st. Four research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. Based on data from MarketBeat, Cooper Companies has a consensus rating of “Moderate Buy” and a consensus price target of $111.78.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.